الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
11 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Amen Hamdy Zaki Ali 2023
12 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
13 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
14 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Amany Mohammed Abdel Moatamed 2023
15 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Prof. Ashraf Zeidan Abdalla Ahmed 2023
16 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Salah Mabrouk Khallaf Abd Rabou 2023
17 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Dr. Maged Abdelfatah Amine Hassan 2021
18 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Hossam El-Din / Mostafa Kamel Mohamed 2021
19 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Dr. Adel Gomaa Mohamed Gabr 2021
20 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Dr. Hanaan Ahmed Mohammed Ahmed 2021